Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2025 Filed Mar 12, 2025 20:10 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 3,242 | $499.99 | $1,620,967.58 |
DisclosureSEC source: 0000875320-25-000146 · wk-form4_1741810227.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,239 F1 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 11/22/2024. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 20:11 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
SaleCommon Stock | 3,298 | $500.00 | $1,649,000.00 |
DisclosureSEC source: 0000875320-25-000148 · wk-form4_1741810299.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,671 F1 · kind: Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:08 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 4,058 | $485.49 | $1,970,118.42 |
DisclosureSEC source: 0000875320-25-000141 · wk-form4_1741295323.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,481 F1 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 11/22/2024. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:08 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
SaleCommon Stock | 3,231 | $490.00 | $1,583,190.00 |
DisclosureSEC source: 0000875320-25-000139 · wk-form4_1741208889.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,743 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:23 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
SaleCommon Stock | 1,272 | $480.00 | $610,560.00 |
DisclosureSEC source: 0000875320-25-000120 · wk-form4_1740777806.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,974 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:36 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
SaleCommon Stock | 2,650 | $475.34 | $1,259,651.00 |
DisclosureSEC source: 0000875320-25-000127 · wk-form4_1740778570.xml · nonDerivative · entry 2 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,352 F1 · kind: Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 02/22/2024. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:48 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 530 | $475.34 | $251,930.20 |
DisclosureSEC source: 0000875320-25-000135 · wk-form4_1740779311.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,539 F1 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:23 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 5,954 | $479.61 | $2,855,597.94 |
DisclosureSEC source: 0000875320-25-000120 · wk-form4_1740777806.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,246 Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:24 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,241 | $479.61 | $595,196.01 |
DisclosureSEC source: 0000875320-25-000122 · wk-form4_1740777887.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,845 Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:31 UTC |
Arbuckle Stuart AEVP, COO
|
Tax withholdingCommon Stock | 7,071 | $479.61 | $3,391,322.31 |
DisclosureSEC source: 0000875320-25-000124 · wk-form4_1740778255.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,935 Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:36 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
Tax withholdingCommon Stock | 2,482 | $479.61 | $1,190,392.02 |
DisclosureSEC source: 0000875320-25-000127 · wk-form4_1740778570.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,002 Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:41 UTC |
Bozic CarmenEVP and CMO
|
Tax withholdingCommon Stock | 4,962 | $479.61 | $2,379,824.82 |
DisclosureSEC source: 0000875320-25-000129 · wk-form4_1740778869.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,669 Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:43 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Tax withholdingCommon Stock | 14,079 | $479.61 | $6,752,429.19 |
DisclosureSEC source: 0000875320-25-000131 · wk-form4_1740779025.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,915 Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:46 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
Tax withholdingCommon Stock | 3,703 | $479.61 | $1,775,995.83 |
DisclosureSEC source: 0000875320-25-000133 · wk-form4_1740779155.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,490 Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:48 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
Tax withholdingCommon Stock | 4,962 | $479.61 | $2,379,824.82 |
DisclosureSEC source: 0000875320-25-000135 · wk-form4_1740779311.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,069 Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:52 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 4,962 | $479.61 | $2,379,824.82 |
DisclosureSEC source: 0000875320-25-000137 · wk-form4_1740779526.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,969 Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 21:04 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
SaleCommon Stock | 848 | $480.95 | $407,845.60 |
DisclosureSEC source: 0000875320-25-000101 · wk-form4_1740603887.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,200 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 21:06 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
SaleCommon Stock | 884 | $480.95 | $425,159.80 |
DisclosureSEC source: 0000875320-25-000103 · wk-form4_1740603976.xml · nonDerivative · entry 2 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,086 F1 · kind: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 21:09 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
SaleCommon Stock | 1,767 | $480.95 | $849,838.65 |
DisclosureSEC source: 0000875320-25-000107 · wk-form4_1740604171.xml · nonDerivative · entry 2 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,484 F1 · kind: Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 02/22/2024. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 21:15 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 354 | $480.95 | $170,256.30 |
DisclosureSEC source: 0000875320-25-000115 · wk-form4_1740604500.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,031 F1 · kind: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:04 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 3,971 | $483.28 | $1,919,104.88 |
DisclosureSEC source: 0000875320-25-000101 · wk-form4_1740603887.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,048 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:06 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 828 | $483.28 | $400,155.84 |
DisclosureSEC source: 0000875320-25-000103 · wk-form4_1740603976.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,970 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:07 UTC |
Arbuckle Stuart AEVP, COO
|
Tax withholdingCommon Stock | 4,716 | $483.28 | $2,279,148.48 |
DisclosureSEC source: 0000875320-25-000105 · wk-form4_1740604066.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,006 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:09 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
Tax withholdingCommon Stock | 1,656 | $483.28 | $800,311.68 |
DisclosureSEC source: 0000875320-25-000107 · wk-form4_1740604171.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,251 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:11 UTC |
Bozic CarmenEVP and CMO
|
Tax withholdingCommon Stock | 3,310 | $483.28 | $1,599,656.80 |
DisclosureSEC source: 0000875320-25-000109 · wk-form4_1740604253.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,631 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:12 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Tax withholdingCommon Stock | 9,386 | $483.28 | $4,536,066.08 |
DisclosureSEC source: 0000875320-25-000111 · wk-form4_1740604345.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,994 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:13 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
Tax withholdingCommon Stock | 2,470 | $483.28 | $1,193,701.60 |
DisclosureSEC source: 0000875320-25-000113 · wk-form4_1740604411.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,193 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:15 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
Tax withholdingCommon Stock | 3,310 | $483.28 | $1,599,656.80 |
DisclosureSEC source: 0000875320-25-000115 · wk-form4_1740604500.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,385 Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:16 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 3,310 | $483.28 | $1,599,656.80 |
DisclosureSEC source: 0000875320-25-000117 · wk-form4_1740604600.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,931 Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:07 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
SaleCommon Stock | 1,111 | $480.00 | $533,280.00 |
DisclosureSEC source: 0000875320-25-000099 · wk-form4_1740431255.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,019 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:21 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
SaleCommon Stock | 671 | $455.06 | $305,345.26 |
DisclosureSEC source: 0000875320-25-000079 · wk-form4_1740000082.xml · nonDerivative · entry 2 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,798 F1 · kind: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:28 UTC |
Biller JonathanEVP and Chief Legal Officer
|
SaleCommon Stock | 1,657 | $455.06 | $754,034.42 |
DisclosureSEC source: 0000875320-25-000085 · wk-form4_1740000492.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,606 F1 · kind: Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/13/2024. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:36 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 244 | $455.06 | $111,034.64 |
DisclosureSEC source: 0000875320-25-000095 · wk-form4_1740000996.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,695 F1 · kind: Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:19 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 2,293 | $463.46 | $1,062,713.78 |
DisclosureSEC source: 0000875320-25-000077 · wk-form4_1739999985.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,130 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:21 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 564 | $463.46 | $261,391.44 |
DisclosureSEC source: 0000875320-25-000079 · wk-form4_1740000082.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,469 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:25 UTC |
Arbuckle Stuart AEVP, COO
|
Tax withholdingCommon Stock | 2,724 | $463.46 | $1,262,465.04 |
DisclosureSEC source: 0000875320-25-000081 · wk-form4_1740000293.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,722 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:26 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
Tax withholdingCommon Stock | 1,529 | $463.46 | $708,630.34 |
DisclosureSEC source: 0000875320-25-000083 · wk-form4_1740000364.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,907 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:28 UTC |
Biller JonathanEVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 1,504 | $463.46 | $697,043.84 |
DisclosureSEC source: 0000875320-25-000085 · wk-form4_1740000492.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,263 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:30 UTC |
Bozic CarmenEVP and CMO
|
Tax withholdingCommon Stock | 1,912 | $463.46 | $886,135.52 |
DisclosureSEC source: 0000875320-25-000087 · wk-form4_1740000615.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,941 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:31 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Tax withholdingCommon Stock | 6,553 | $463.46 | $3,037,053.38 |
DisclosureSEC source: 0000875320-25-000089 · wk-form4_1740000707.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,380 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:33 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Tax withholdingCommon Stock | 6,066 | $463.46 | $2,811,348.36 |
DisclosureSEC source: 0000875320-25-000091 · wk-form4_1740000808.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,026 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:34 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
Tax withholdingCommon Stock | 2,139 | $463.46 | $991,340.94 |
DisclosureSEC source: 0000875320-25-000093 · wk-form4_1740000892.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,663 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:36 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
Tax withholdingCommon Stock | 2,293 | $463.46 | $1,062,713.78 |
DisclosureSEC source: 0000875320-25-000095 · wk-form4_1740000996.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,939 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:38 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,293 | $463.46 | $1,062,713.78 |
DisclosureSEC source: 0000875320-25-000097 · wk-form4_1740001110.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,241 Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 21:17 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
Tax withholdingCommon Stock | 2,525 | $450.83 | $1,138,345.75 |
DisclosureSEC source: 0000875320-25-000071 · wk-form4_1739567825.xml · nonDerivative · entry 2 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,092 Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:03 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
GrantCommon Stock | 5,324 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000055 · wk-form4_1739567001.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,423 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:04 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
GrantCommon Stock | 2,080 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000057 · wk-form4_1739567081.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,033 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:06 UTC |
Arbuckle Stuart AEVP, COO
|
GrantCommon Stock | 7,903 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000059 · wk-form4_1739567177.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,446 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:08 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
GrantCommon Stock | 6,211 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000061 · wk-form4_1739567303.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,436 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:10 UTC |
Biller JonathanEVP and Chief Legal Officer
|
GrantCommon Stock | 4,437 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000063 · wk-form4_1739567406.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,767 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.